Purchases and Sales Made in Q3 2022 in Revance Therapeutics, Inc. (RVNC)
This table provides information about the institutional ownership of Revance Therapeutics, Inc. (RVNC) during Q3 2022. The information is specifically focused on institutions that hold shares of Revance Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-74K- 42.24% |
$1.06M - $2.11M
|
101K
$260K
|
|
|
Nov 14, 2022
Q3 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-139K- 56.52% |
$1.99M - $3.95M
|
107K
$274K
|
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-163K- 9.18% |
$2.34M - $4.65M
|
1.62M
$4.15M
|
|
|
Nov 01, 2022
Q3 2022
|
Rice Hall James & Associates, LLC
|
SELL
|
- |
-189K- 17.38% |
$2.7M - $5.37M
|
897K
$2.3M
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-227K- 48.38% |
$3.26M - $6.48M
|
243K
$624K
|
|
|
Nov 09, 2022
Q3 2022
|
High Tower Advisors, LLC
Chicago, IL |
SELL
|
- |
-369K- 30.12% |
$5.28M - $10.5M
|
855K
$2.2M
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-440K- 57.12% |
$6.3M - $12.5M
|
330K
$848K
|
|
|
Nov 01, 2022
Q3 2022
|
Jennison Associates LLC
|
SELL
|
- |
-683K- 38.93% |
$9.79M - $19.5M
|
1.07M
$2.76M
|
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.24M- 18.5% |
$17.7M - $35.2M
|
5.45M
$14M
|
|
|
Nov 14, 2022
Q3 2022
|
Health Cor Management, L.P.
New York, NY |
SELL
|
- |
-1.35M- 95.45% |
$19.4M - $38.5M
|
64.6K
$166K
|